Smith v. United States

CourtDistrict Court, M.D. Tennessee
DecidedJuly 25, 2022
Docket3:19-cv-00600
StatusUnknown

This text of Smith v. United States (Smith v. United States) is published on Counsel Stack Legal Research, covering District Court, M.D. Tennessee primary law. Counsel Stack provides free access to over 12 million legal documents including statutes, case law, regulations, and constitutions.

Bluebook
Smith v. United States, (M.D. Tenn. 2022).

Opinion

UNITED STATES DISTRICT COURT MIDDLE DISTRICT OF TENNESSEE NASHVILLE DIVISION

JERROD SMITH, ) ) Petitioner, ) ) v. ) NO. 3:19-cv-00600 ) UNITED STATES OF AMERICA, ) ) Respondent. )

MEMORANDUM OPINION AND ORDER

Jerrod Smith was convicted of conspiracy to commit mail fraud, mail fraud, and obstruction of justice in 2018. A jury found he and his co-conspirator falsified drug pedigree documents, dealt with unlicensed drug suppliers, and fraudulently sold prescription medications through their pharmaceutical wholesale company, Cumberland Distribution (“Cumberland”). Mr. Smith received a 180-month sentence. He filed a pro se petition to vacate that sentence under 28 U.S.C. § 2255, alleging his trial attorney, Thomas Kendrick, was ineffective. (Doc. No. 1). Mr. Smith later retained counsel and filed an amended petition that incorporated and expanded upon his pro se petition. (Doc. No. 11). Mr. Smith’s claim has been fully briefed (Doc. Nos. 16, 42, 43, 47, 48), and the Court held an evidentiary hearing regarding it (Doc. Nos. 40, 41). The Court will deny Mr. Smith’s request for relief. I. BACKGROUND1 A. Mr. Smith’s Professional History and Criminal Proceedings. In 2007, Mr. Smith and Jeffrey Edwards co-founded Cumberland. (Doc. No. 1 at 1). They

1 The Court did not find Mr. Smith credible at the evidentiary hearing, as outlined in Section I.B. Accordingly, the Court relies primarily on exhibits and other witnesses’ testimony for its factual findings on disputed issues. On certain undisputed issues, it relies on information from Mr. Smith. each owned half of the equity in the company. (Id.). Mr. Smith served as President of Cumberland, whereas Mr. Edwards served as its Chief Executive Officer. (Id.). Mr. Edwards’ wife, Brenda, also worked at Cumberland. (Id. at 2). She assisted with product procurement. (Id.). Around 2008, the Food and Drug Administration (“FDA”) started an investigation into

Cumberland. (Doc. No. 41 at 99). The investigation was headed by Special Agent Bob West. (Id.). The FDA suspected that Cumberland was “buying drugs off the street in Miami [and] in New York, repurposing them, and putting them back into the wholesale market and distributing those to pharmacies throughout the United States.” (Id. at 99–100). In May 2009, as part of its investigation, the FDA raided a Cumberland warehouse. (See Doc. No. 1 at 2). It seized computers, files, and company inventory. (Id.). In September 2009, Mr. Smith and Mr. Edwards agreed to meet with the government in a proffer session to discuss its investigation. (Id.). Both men were represented by Anthony Osso at the time. (Id.). According to a government interview memorandum, during the proffer session, Mr. Smith stated that he “did not trust” the drugs coming to Cumberland from one of its suppliers, “however, he distributed them anyways.” (Ex. 2).2 The memorandum was written by Agent West. (Id.; Doc. No. 41 at

102). Subsequently, Mr. Smith retained Jennifer Thompson as his independent counsel. (Doc. No. 41 at 8). In April 2010, assisted by Ms. Thompson, Mr. Smith attended a second proffer session with Agent West. (Doc. No. 11 at 11). Mr. Smith made inculpatory statements during the interview. (Doc. No. 41 at 14). According to an interview summary written by Agent West, Mr. Smith “admitted that he knew the drugs coming to Cumberland were being obtained from

2 The Court refers to the parties’ exhibits from the evidentiary hearing in this matter in the following form: “Ex. __.” illegitimate or unscrupulous sources. He also acknowledged that he knew what they were doing was illegal in the fact that the drugs being shipped to . . . independent pharmacies could not be verified since he and others knew the drugs were coming from unlicensed wholesalers.” (Ex. 4). After the proffer session, Ms. Thompson told Mr. Smith that the government “was going

in the direction of wanting [him] to plead guilty.” (Doc. No. 41 at 63). She talked to the government about resolving the case pre-indictment. (Id. at 136). The government drafted a plea agreement and sent the draft to Ms. Thompson. (Id. at 137; Ex. 7). The plea agreement recommended an offense level for Mr. Smith of 35.3 (Ex. 7 at 9). It stated that the parties had no agreement regarding Mr. Smith’s criminal history category. (Id.). But even at the lowest possible criminal history category, an offense level of 35 would have corresponded to a sentencing guidelines range of 168–210 months of imprisonment.4 The agreement also contemplated that the government might file a U.S.S.G. § 5K1.1 motion on Mr. Smith’s behalf. (Id. at 11–12). According to Ms. Thompson, the government was “willing to take 50 percent off” based on Mr. Smith’s cooperation. (Doc. No. 41 at 129).

Ms. Thompson spoke to Mr. Smith about the plea offer. (Id. at 138–39). She advised him to plead guilty and cooperate. (Id. at 140). Mr. Smith did not accept her advice. He told her “I really don’t want to serve any prison time.” (Id. at 138). He fired her in April 2011 (Ex. 11) and

3 This level assumed a two-level reduction for acceptance of responsibility and a one-point reduction for Mr. Smith’s timely notice of his intent to plead. (Ex. 7 at 8). Absent those reductions, the plea agreement would set the offense level at 38. (Id.).

4 The Court has taken judicial notice of the Sentencing Guidelines effective as of November 1, 2010. See Fed. R. Evid. 201 (“The court may judicially notice a fact that is not subject to reasonable dispute because it: (1) is generally known within the trial court’s territorial jurisdiction; or (2) can be accurately and readily determined from sources whose accuracy cannot reasonably be questioned.”). That is the version of the Sentencing Guidelines contemplated in the draft plea agreement. (Ex. 7 at 7). stated in a power of attorney document that “her goals in the case do not appear to coincide with mine” (Ex. 12). Mr. Smith replaced Ms. Thompson with Mr. Kendrick. (Id.). Mr. Smith’s first meeting with Mr. Kendrick was a “group meeting at his office.” (Doc. No. 41 at 21). In addition to Mr. Smith and Mr. Kendrick, two acquaintances of Mr. Smith—Tom

Lane and Gene Morrison—were present. (Id.). During the meeting, the four men discussed Mr. Smith’s role at Cumberland, his criminal case, his proffer session with the government, and the pharmaceutical distribution business. (Id. at 21–22). Mr. Smith claims he admitted he “was culpable” during that meeting. (Id. at 23). However, the record contradicts that statement; it appears Mr. Smith told Mr. Kendrick he was innocent.5 Mr. Kendrick’s intake memorandum for Mr. Smith’s case says that Mr. Smith “at no time had any knowledge that anything was wrong about the business dealings of Cumberland and still does not know that there was anything wrong about such dealings.” (Ex. 31 at 4). And an email Mr. Kendrick sent to a colleague years later, in 2018, indicates Mr. Smith consistently told Mr. Kendrick he was innocent throughout their relationship. (Ex. 23 at 1 (“The real bottom line is that I cannot plead a client guilty unless he is

guilty. My client insists, and has insisted since 2011, that he is not.”)). Based in part on the information discussed at the initial meeting, Mr. Kendrick formed a trial theory of Mr. Smith’s case. (Doc. No. 41 at 23). He believed “Agent West . . . was not 100 percent credible and that . . . they could punch holes in any type of statement that he gave.” (Id. at 23–24). At some point after the meeting, Mr. Kendrick asked Mr. Smith to “write any thoughts or discrepancies that [he] might have” regarding Agent West’s summary of Mr. Smith’ 2010 proffer. (Id. at 26). Mr. Smith did so. (Ex. 13). In August 2012, he sent Mr.

Free access — add to your briefcase to read the full text and ask questions with AI

Related

Illinois v. Gates
462 U.S. 213 (Supreme Court, 1983)
Strickland v. Washington
466 U.S. 668 (Supreme Court, 1984)
Holland v. Jackson
542 U.S. 649 (Supreme Court, 2004)
Harrington v. Richter
131 S. Ct. 770 (Supreme Court, 2011)
Lafler v. Cooper
132 S. Ct. 1376 (Supreme Court, 2012)
Marshall Dwayne Hughes v. United States
258 F.3d 453 (Sixth Circuit, 2001)
Alton Higgins v. Paul Renico
470 F.3d 624 (Sixth Circuit, 2006)
Webb v. Mitchell
586 F.3d 383 (Sixth Circuit, 2009)
Burt v. Titlow
134 S. Ct. 10 (Supreme Court, 2013)
Jackson v. Warden, Chillicothe Correctional Institution
622 F. App'x 457 (Sixth Circuit, 2015)
Manley v. Ross Correctional Institution
314 F. App'x 776 (Sixth Circuit, 2008)

Cite This Page — Counsel Stack

Bluebook (online)
Smith v. United States, Counsel Stack Legal Research, https://law.counselstack.com/opinion/smith-v-united-states-tnmd-2022.